Cargando…

Soluble ACE2 in SARS-CoV-2 infection

Detalles Bibliográficos
Autor principal:	Allison, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985737/ https://www.ncbi.nlm.nih.gov/pubmed/33758362 http://dx.doi.org/10.1038/s41581-021-00422-6

Ejemplares similares

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
por: Monteil, Vanessa, et al.
Publicado: (2020)

Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection
por: Hassler, Luise, et al.
Publicado: (2023)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022)

Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
por: Wang, Cheng, et al.
Publicado: (2020)

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
por: Natekar, Janhavi Prasad, et al.
Publicado: (2022)

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
por: Miao, Xiaoniu, et al.
Publicado: (2020)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
por: Bar-On, Liat, et al.
Publicado: (2022)

Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Yeung, Man Lung, et al.
Publicado: (2022)

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
por: Malik, Johid Reza, et al.
Publicado: (2023)

Spatial resolution of SARS-CoV-2 lung infection
por: Pia, Luisanna
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals
por: Hayashi, Takuma, et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
por: Monteil, Vanessa, et al.
Publicado: (2020)

Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
por: Kayabolen, Alisan, et al.
Publicado: (2022)

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
por: Case, James Brett, et al.
Publicado: (2020)

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
por: C., Selvaa Kumar, et al.
Publicado: (2020)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Development of ACE2 autoantibodies after SARS-CoV-2 infection
por: Arthur, John M., et al.
Publicado: (2021)

Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells
por: Kroll, Marie-Kristin, et al.
Publicado: (2023)

Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
por: Shukla, Nidhi, et al.
Publicado: (2021)

Cross-reactive memory T cells abort SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

Attacking the defence: SARS-CoV-2 can infect immune cells
por: Borsa, Mariana, et al.
Publicado: (2020)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Dietary fish intake increased the concentration of soluble ACE2 in rats: can fish consumption reduce the risk of COVID-19 infection through interception of SARS-CoV-2 by soluble ACE2?
por: O’Keeffe, Maria, et al.
Publicado: (2023)

Searching for relatives of SARS-CoV-2 in bats
por: York, Ashley
Publicado: (2021)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

Getting to the (germinal) centre of SARS-CoV-2
por: Richter, Felix Clemens, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g501o8eei3ssg9dpnmklt8qt99